Measurement of CA15-3 level among women attending the surgery department at Brack General Hospital – South of Libya
DOI:
https://doi.org/10.51984/joms.v17i2.2287Keywords:
Breast cancer, CA15-3, Tumor marker, DiagnosisAbstract
CA15-3 is one of the most widely used tumor markers for diagnosing and monitoring therapy of breast cancer. However, scientific studies have differed significantly in the importance of measuring this antigen for early diagnosis of breast cancer.The study was conducted on 72 women who visited the surgery department of the Brack general hospital, The concentration of CA15-3 was measured using enzyme-linked immunosorbent assay (ELISA).The results showed that the level of CA15-3 was elevated in 2 samples (2.77%) with a mean level of 38.5 ± 1.7 U/ mL, and 70 samples (97.23%) was were normal with a mean level of 13.77 ± 6.17 U/ml. The statistical analysis showed significant differences between the concentrations in the high and normal samples (P = 0.00). We conclude that CA15-3 is not a reliable test to confirm breast cancer.
Downloads
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2022 Journal of Medical Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This article is published open access under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). You may copy, redistribute, adapt and build upon it for non-commercial purposes, provided you credit the authors, cite the original publication in the Journal of Medical Sciences with its DOI, indicate any changes, and distribute any adaptations under the same licence. Copyright rests with the authors. For commercial reuse, please contact the corresponding author. Full terms: https://sebhau.edu.ly/journal/joms/copyright-licensing




















